Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Cost savings associated with filling a 3-month supply of prescription medicines.

Rabbani A, Alexander GC.

Appl Health Econ Health Policy. 2009;7(4):255-64. doi: 10.2165/11313610-000000000-00000.

PMID:
19905039
2.

Out-of-pocket and total costs of fixed-dose combination antihypertensives and their components.

Rabbani A, Alexander GC.

Am J Hypertens. 2008 May;21(5):509-13. doi: 10.1038/ajh.2008.31. Epub 2008 Mar 20.

PMID:
18437141
3.

Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs.

Alexander GC, Zhang J, Basu A.

Med Care. 2008 Apr;46(4):394-402. doi: 10.1097/MLR.0b013e3181618ee0.

PMID:
18362819
4.

Role of health insurance coverage in women's access to prescription medicines.

Ranji UR, Wyn R, Salganicoff A, Yu H.

Womens Health Issues. 2007 Nov-Dec;17(6):360-6.

PMID:
18042485
5.
6.

Medicare-approved drug discount cards and renal transplant patients: how much can these cards reduce prescription costs?

Chisholm MA, Marshall J, Smith KE, Garrett CJ, Turner JC.

Clin Transplant. 2005 Jun;19(3):357-63.

PMID:
15877798
7.

Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.

Haas JS, Phillips KA, Gerstenberger EP, Seger AC.

Ann Intern Med. 2005 Jun 7;142(11):891-7.

PMID:
15941695
8.

Short-term persistence of high health care costs in a nationally representative sample of children.

Liptak GS, Shone LP, Auinger P, Dick AW, Ryan SA, Szilagyi PG.

Pediatrics. 2006 Oct;118(4):e1001-9.

PMID:
17015496
9.

Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S.

N Engl J Med. 1987 Aug 27;317(9):550-6.

PMID:
3302713
10.

Association between medication supplies and healthcare costs in older adults from an urban healthcare system.

Stroupe KT, Murray MD, Stump TE, Callahan CM.

J Am Geriatr Soc. 2000 Jul;48(7):760-8.

PMID:
10894314
11.

Racial and ethnic disparities in the financial burden of prescription drugs among older Americans.

Xu KT, Borders TF.

J Health Hum Serv Adm. 2007 Summer;30(1):28-49.

PMID:
17557695
12.
14.

Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey.

Law AW, Reed SD, Sundy JS, Schulman KA.

J Allergy Clin Immunol. 2003 Feb;111(2):296-300.

PMID:
12589348
15.
16.

Impact of the Medicare modernization act on low-income persons.

Havrda DE, Omundsen BA, Bender W, Kirkpatrick MA.

Ann Intern Med. 2005 Oct 18;143(8):600-8.

PMID:
16230727
17.

Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia.

Darkow T, Henk HJ, Thomas SK, Feng W, Baladi JF, Goldberg GA, Hatfield A, Cortes J.

Pharmacoeconomics. 2007;25(6):481-96.

PMID:
17523753
19.
20.

Choices in prescription-drug benefit programs: mail versus community pharmacy services.

Kirking DM, Ascione FJ, Richards JW.

Milbank Q. 1990;68(1):29-51. Review.

PMID:
2215427

Supplemental Content

Support Center